Clinical Trials
3 trialsNCT01540812 2020-03-09
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
PETHEMA Foundation
Completed
NCT03349957 2018-04-25
TANDEM-IDA
University Hospital, Montpellier
Completed
NCT01889407 2015-04-21
Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Nanfang Hospital, Southern Medical University
Unknown